Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention - PubMed (original) (raw)
Review
Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention
P Pozzilli et al. Diabetes Care. 2001 Aug.
Abstract
Type 1 diabetes is caused by the immune-mediated destruction of islet insulin-secreting beta-cells. This chronic destructive process is associated with both cellular and humoral immune changes in the peripheral blood that can be detected months or even years before the onset of clinical diabetes. Throughout this prediabetic period, metabolic changes, including altered glucose tolerance and reduced insulin secretion, deteriorate at variable rates and eventually result in clinical diabetes. A fraction of individuals with humoral immunological changes have clinical diabetes that initially is not insulin-requiring. The onset of diabetes in these patients is usually in adult life, and because their diabetes is at least initially not insulin-requiring, they appear clinically to be affected by type 2 diabetes. Such patients probably have the same disease process as patients with type 1 diabetes in that they have similar HLA genetic susceptibility as well as autoantibodies to islet antigens, low insulin secretion, and a higher rate of progression to insulin dependency. These patients are defined as being affected by an autoimmune type of diabetes not requiring insulin at diagnosis, which is also named latent autoimmune diabetes of the adult (LADA). Special attention should be paid to diagnose such patients because therapy may influence the speed of progression toward insulin dependency, and in this respect, efforts should be made to protect residual C-peptide secretion. LADA can serve as a model for designing new strategies for prevention of type 1 diabetes but also as a target group for prevention in its own right.
Similar articles
- [Latent autoimmune diabetes in adults: an update].
Zhou ZG, Li X. Zhou ZG, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Oct;25(5):630-4. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003. PMID: 14650175 Review. Chinese. - Type I diabetes masquerading as type II diabetes. Possible implications for prevention and treatment.
Leslie RD, Pozzilli P. Leslie RD, et al. Diabetes Care. 1994 Oct;17(10):1214-9. doi: 10.2337/diacare.17.10.1214. Diabetes Care. 1994. PMID: 7821148 Review. - [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
Pánczél P, Hosszúfalusi N, Bornemisza B, Horváth L, Jánoskuti L, Füst G, Rajczy K, Vatay A, Prohászka Z, Madácsy L, Luczay A, Blatniczky L, Halmos T, Körner A, Szilvási I, Romics L. Pánczél P, et al. Orv Hetil. 2001 Nov 18;142(46):2571-8. Orv Hetil. 2001. PMID: 11770176 Hungarian. - Impaired insulin secretion in non-diabetic offspring of probands with latent autoimmune diabetes mellitus in adults.
Vauhkonen I, Niskanen L, Knip M, Ilonen J, Vanninen E, Kainulainen S, Uusitupa M, Laakso M. Vauhkonen I, et al. Diabetologia. 2000 Jan;43(1):69-78. doi: 10.1007/s001259900177. Diabetologia. 2000. PMID: 10663218 - Diabetes classification: grey zones, sound and smoke: Action LADA 1.
Leslie RD, Kolb H, Schloot NC, Buzzetti R, Mauricio D, De Leiva A, Yderstraede K, Sarti C, Thivolet C, Hadden D, Hunter S, Schernthaner G, Scherbaum W, Williams R, Pozzilli P. Leslie RD, et al. Diabetes Metab Res Rev. 2008 Oct;24(7):511-9. doi: 10.1002/dmrr.877. Diabetes Metab Res Rev. 2008. PMID: 18615859 Review.
Cited by
- Global Trends in LADA Type Diabetes Research: A Bibliometric Analysis of Publications from Web of Science and Scopus, 1994-2024.
Kudabayeva K, Tleumagambetova B, Bazargaliyev Y, Kosmuratova R, Zhylkybekova A. Kudabayeva K, et al. J Diabetes Res. 2024 Oct 14;2024:4960075. doi: 10.1155/2024/4960075. eCollection 2024. J Diabetes Res. 2024. PMID: 39435133 Free PMC article. - Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.
Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Lernmark Å, Metzger BE, Nathan DM, Kirkman MS. Sacks DB, et al. Diabetes Care. 2023 Oct 1;46(10):e151-e199. doi: 10.2337/dci23-0036. Diabetes Care. 2023. PMID: 37471273 Free PMC article. Review. - Development and validation of a clinical score for identifying patients with high risk of latent autoimmune adult diabetes (LADA): The LADA primary care-protocol study.
Vich-Pérez P, Abánades-Herranz JC, Mora-Navarro G, Carrasco-Sayalero ÁM, Salinero-Fort MÁ, Sevilla-Machuca I, Sanz-Pascual M, Álvarez Hernández-Cañizares C, de Burgos-Lunar C; LADA-PC Research Consortium. Vich-Pérez P, et al. PLoS One. 2023 Feb 9;18(2):e0281657. doi: 10.1371/journal.pone.0281657. eCollection 2023. PLoS One. 2023. PMID: 36758065 Free PMC article. - Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto's thyroiditis: a case report.
Xenou M, Zoupas I, Lygnos D, Fousteris E. Xenou M, et al. J Med Case Rep. 2022 Aug 3;16(1):297. doi: 10.1186/s13256-022-03523-3. J Med Case Rep. 2022. PMID: 35918735 Free PMC article. - Effects of Berberine Plus Inulin on Diabetes Care in Patients With Latent Autoimmune Diabetes in Adults: Protocol for a Randomized Controlled Trial.
Zhang R, Xiao Y, Yan J, Yang W, Wu X, Mei Z, Zhou Z. Zhang R, et al. Front Endocrinol (Lausanne). 2022 Jun 15;13:876657. doi: 10.3389/fendo.2022.876657. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35784546 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials